COVID vs ECCMID 2024
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
COVID
This app offers a comprehensive, evidence-based resource for drug-drug interactions related to COVID-19. It is designed to be clinically useful and reliable for healthcare professionals, patients, and researchers.
- Clinically useful drug interactions
- Reliable evidence-based resource
- Comprehensive COVID-19 drug information
- Up-to-date data
- Free for healthcare workers, patients, and researchers
Read full descriptionHide full description
We provide a clinically useful, reliable, comprehensive, up-to-date, evidence-based drug-drug interaction resource, freely available to healthcare workers, patients and researchers.
ECCMID 2024
Read full descriptionHide full description
This is the official app of the 34th ECCMID, which will take place in Barcelona, Spain, from 27 - 30 April 2024. Leading experts will come together to discuss the latest developments in infectious diseases, infection control and clinical microbiology. Engage in a cutting-edge medical congress, while experiencing the city's irresistible charm. Barcelona offers the perfect fusion of knowledge and adventure. With the app you will have access to the scientific programme, floorplans, abstracts and networking opportunities.
Screenshots
Verdict
The clearest difference is update cadence: ECCMID 2024 at daily against COVID's every 16 months. COVID's advantage is iOS requirement (11.0 vs 14.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
COVID ships an update every 16 months, ECCMID 2024 daily. The most recent releases landed on October 24, 2026 and October 2, 2026 respectively.
| Parameter | COVID | ECCMID 2024 |
|---|---|---|
| Price | Free | Free |
| Rating | 3.7 (3 ratings) — better | — |
| Positive reviews | 16.7% of reviews | — |
| Number of ratings | 3 — better | — |
| Update frequency | Every 16 months | Daily — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 — better | 14.0 |
| Further details — not scored | ||
| Size | 13 MB | 94 MB |
| Age rating | 17+ | 17+ |
| Developer | Liverpool Drug Interactions Group | key4events |
In-app purchases
COVID
No in-app purchases
ECCMID 2024
No in-app purchases
